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ABSTRACT  
Purpose: Miscibility of the different compounds that make up a solid dispersion based 
formulation play a crucial role in the drug release profile and physical stability of the solid 
dispersion as it defines the phase behaviour of the dispersion. The standard technique to 
obtain information on phase behaviour of a sample is (modulated) differential scanning 
calorimetry ((M)DSC). However, for ternary mixtures (M)DSC alone is not sufficient to 
characterize their phase behaviour and to gain insight into the distribution of the active 
pharmaceutical ingredient (API) in a two-phased polymeric matrix.  
Methods: MDSC was combined with complementary surface analysis techniques, 
specifically time-of-flight secondary ion mass spectrometry (ToF-SIMS) and atomic force 
microscopy (AFM). Three spray-dried model formulations with varying API/PLGA/PVP 
ratios were analyzed. 
Results: The distribution of the API in the ternary solid dispersions depended on formulation 
parameters. The extent of API surface coverage and therefore the distribution of the API over 
both polymeric phases differed significantly for the three formulations. 
Conclusions: Combining (M)DSC and surface analysis rendered additional insights in the 
composition of mixed phases in complex systems, like ternary solid dispersions. 
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ABBREVIATIONS 
AFM   atomic force microscopy  
API    active pharmaceutical ingredient  
DDS   drug delivery system 
(M)DSC  (modulated) differential scanning calorimetry 
HIV   human immunodeficiency virus 
PLGA   poly(lactic-co-glycolic acid)  
PVP   polyvinylpyrrolidone 
Tg   glass transition temperature 
ToF-SIMS   time of flight secondary ion mass spectrometry  
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INTRODUCTION  
Solid dispersions are an intensively investigated enabling technology to formulate poorly 
soluble drugs so as to improve their bioavailability (1–5). Phase behaviour of the different 
compounds plays a crucial role in this type of formulation as it will determine whether a given 
drug-polymer combination will be present as a glass solution (molecular dispersion) or a 
phase separated system (amorphous-amorphous or amorphous-crystalline phase separation). 
Hence, the phase behaviour will have an influence on the release profile and stability 
performance of such a formulation. The technique of (Modulated) differential scanning 
calorimetry ((M)DSC) is generally used to study the phase behaviour and miscibility of a drug 
delivery system (DDS). Based upon the experimentally observed glass transition temperatures 
(Tgs) the phase behaviour and composition of binary drug-polymer mixtures can be estimated 
by a number of expressions such as the Gordon-Taylor, Fox or Couchman-Karasz equation. 
All of these equations are mathematical derivations on the same theme and were originally 
developed for ideal binary polymer systems (6). For binary pharmaceutical samples the 
Gordon-Taylor equation is the most frequently used expression to describe the relationship 
between the Tg and sample composition (7). A similar expression for ternary mixtures has 
been developed but finds limited application due to the contradiction between the complexity 
of ternary mixtures and the assumptions made for this model equation (6). Therefore for 
ternary mixtures (M)DSC alone is not sufficient to characterize the composition of the 
different phases present, as for a mixed phase it is virtually impossible to determine the 
weight fraction of each of the three compounds. Knowledge of the composition of the 
different phases would inform on the distribution of a drug throughout the DDS. 
Inhomogeneous drug distribution, such as surface enrichment, can only be detected by 
comparing the bulk characteristics of that formulation to its surface properties, indicating the 
need of surface analysis for ternary solid dispersions.  
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Information on both phase behaviour and spatial drug distribution is indispensable as these 
characteristics can be decisive for the release characteristics of a solid dispersion. For 
example, phase behaviour might influence the release, as particles containing a poorly soluble 
drug in the form of amorphous precipitates in the polymeric matrix are likely to have a slower 
release compared to ideal glass solutions where the drug is molecularly dispersed within a 
matrix. Spatial drug distribution might also influence the performance of a solid dispersion. 
For instance, enrichment of drug at the surface results in an increased size or number of 
(amorphous) drug domains at the surface. This jeopardizes the increased solubility originating 
from the (molecular) dispersion of the poorly soluble drug. In that way surface-bulk 
distribution of the drug will determine the release kinetics of the sample. Additionally surface 
enrichment of an amorphous drug makes the solid dispersion more prone to surface 
crystallization and therefore might be detrimental to its stability. These issues highlight why 
surface characterization of solid dispersions is crucial in understanding how they perform 
with respect to dissolution and stability.  
 
We have previously reported on the development of spray-dried polymeric microspheres for 
intramuscular injection for the long-term prophylaxis of infection with human 
immunodeficiency virus (HIV) (8,9).  These shell structured microspheres contain two 
biocompatible polymers, poly(lactic-co-glycolic acid) (PLGA) and polyvinylpyrrolidone 
(PVP) and are made up of a PLGA-rich surface layer and an underlying PVP-rich phase (8). 
MDSC analysis revealed, based upon the Gordon-Taylor equation, that the polymeric 
microspheres are estimated to consist of a PLGA-rich surface phase (85% PLGA, 15% PVP) 
and a PVP-rich underlying phase (97% PVP, 3% PLGA) (9).   
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For the present study a poorly soluble active pharmaceutical ingredient (API) was dispersed in 
these microspheres as a solid dispersion. The model drug used was an HIV protease inhibitor. 
Three model formulations with varying ratios of API/PLGA/PVP were developed. As 
mentioned above, after inclusion of the API the composition of the mixed phases cannot be 
determined by (M)DSC. To discern the distribution of the API in the microspheres and thus 
the ternary solid dispersions, (M)DSC was combined with surface analysis techniques, 
namely ToF-SIMS and AFM. The potential of this combination lies in the complementarity of 
the techniques. (M)DSC is a bulk thermo-analytical technique, whereas ToF-SIMS is a 
surface mass spectrometry technique capable of analyzing the top 1-2 nm. AFM enables 
spatial characterization of topographic and mechanical properties of a sample surface at 
nanoscale resolution. 
 
For ToF-SIMS analysis, chemical identification of different compounds at the sample surface 
is based upon the detection of secondary ions, including molecular species or fragments 
derived from these compounds. Besides chemical identification, this technique can also 
provide information on spatial distribution of compounds at the sample surface via ToF-SIMS 
chemical imaging. The utility of ToF-SIMS for the analysis of solid dispersions lies mainly in 
its potential to reveal the spatial distribution of drug and excipient at the sample surface (9–
12). Evidently, this information is indispensable for complete characterization of solid 
dispersions.  Homogeneous mixing, at least at the resolution of the ToF-SIMS data (on the 
order of microns) is assessed by uniformity of the drug and polymer distribution at the sample 
surface.  
 
The main contribution of AFM for the analysis of solid dispersions lies in its potential to 
spatially resolve the phase separation at nanoscale resolution (9,13–16). Although this 
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technique is not yet that frequently used for the characterization of pharmaceutical samples, it 
exhibits great potential as various mechanical properties (eg. stiffness, adhesion and friction) 
can be monitored to distinguish different compounds. 
 
This study aims to clarify drug distribution in a multi-phased polymeric system. To do so, for 
the first time, (M)DSC was combined with ToF-SIMS and AFM to characterize the phase 
behaviour of ternary solid dispersions. 
 
 
MATERIALS AND MATHODS 
Materials 
Poly(lactic-co-glycolic acid) (PLGA) (lactide:glycolide molar ratio of 75:25, inherent 
viscosity of 0.2 dl/g) was purchased from PURAC Biomaterials (Gorinchem, The 
Netherlands). Polyvinylpyrrolidone K30 (PVP K30) (MW 44-54 kDa) was kindly donated by 
BASF (Ludwigshafen, Germany). The API was a poorly soluble HIV protease inhibitor 
provided by Janssen (Beerse, Belgium) and its structure is shown in Figure 1.  
Dichloromethane (DCM) was provided by Fisher Scientific (Leicestershire, United 
Kingdom).  
 
FIGURE 1 Structural formula of the API, a poorly soluble HIV protease inhibitor. 
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Methods  
Spray drying 
Three model ternary solid dispersions made up of API, PLGA and PVP were prepared by 
spray drying and had the following composition: 10/75/15, 20/50/30 and 30/25/45 wt% 
API/PLGA/PVP. Samples were spray dried with a Micro Spray lab scale spray dryer 
(ProCepT, Zelzate, Belgium) starting from a 5% feed solution in dichloromethane (DCM). 
The inlet temperature was set to 115°C and the feed rate was 6 mL/min. The co-current 
drying air had a flow rate of 0.2 m³/min and the atomizing air was supplied with a pressure of 
1.25 bar.  
 
Modulated differential scanning calorimetry 
The bulk miscibility behaviour of the spray-dried microspheres was determined by MDSC 
(Q2000, TA Instruments, Leatherhead, UK). Thermal Analysis Software (Version 4.4A) was 
used to analyze the obtained data. Crimped aluminum pans (TA Instruments, Brussels, 
Belgium) were selected for the analysis of the samples. An empty pan was used as a reference 
and the masses of the reference pan and of the sample pans were taken into account. The DSC 
cell was purged with a nitrogen flow rate of 50 mL/min.  
Indium and octadecane were chosen for temperature calibration. The enthalpic response was 
calibrated with indium. The modulation parameters used were a heating rate of 1°C/min, a 
period of 40 s and an amplitude of 1°C. Calibration of the heat capacity was done using 
sapphire. Samples were analyzed from -20°C to 220°C. Glass transitions were analyzed in the 
reversing heat flow signals. 
 
Scanning electron microscopy 
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SEM was used to study the morphology and particle size of the samples which were prepared 
by fixing an amount of powder on an aluminum stub using double-sided carbon tape. The 
samples were coated with a gold-palladium mixture by sputtering for 45 s at 20 mA. Field 
emission gun scanning electron micrographs (FEG-SEM) were taken by using a Philips XL30 
ESEM-FEG instrument (Philips, Eindhoven, The Netherlands) at an acceleration voltage of 
10 kV.  
 
Time-of-flight secondary ion mass spectrometry 
Spray-dried samples were adhered to double-sided adhesive tape in order to produce an 
immobile surface suitable for ToF-SIMS analysis. The data were acquired using a ToF-SIMS 
IV instrument (ION-TOF GmbH) equipped with a bismuth liquid metal ion gun and a single-
stage reflectron analyzer. Typical operating conditions utilised a 25 kV Bi3
+ 
primary ion 
source with a pulsed target current of approximately 0.3 pA. A flood gun producing low 
energy electrons (20 eV) was used to compensate for surface charging caused by the 
positively charged primary ion beam on the insulating sample surface. A 4 mm × 4 mm area 
of each sample was raster scanned at a resolution of 100 pixels per mm. PLGA and PVP were 
identified using C6H7O4
-
 (m/z = 143), and C5H8O
-
 (m/z = 84) respectively. The API was 
characterized by C8H7SO3
-
 (m/z = 183). Prior to sample analysis, reference materials were 
analyzed and the characteristic ion peaks C6H7O4
-
, C5H8O
- 
and C8H7SO3
-
 were selected and 
only present in PLGA, PVP and API respectively. Negative polarity ToF-SIMS spectra 
showing the markers for API, PLGA and PVP are shown in Figure 1 of the Supplementary 
Information. Static conditions were ensured by keeping the total primary ion beam dose for 
every analyzed area below 1 × 10
12 
ions/cm² throughout the analysis. Data in the negative 
secondary ion polarities were collected and analyzed using SurfaceLab 6 software (IONTOF). 
For any given sample, the measured secondary ion intensity for each polymer and API marker 
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peak was normalized to the total intensity count to enable a semi-quantitative comparison of 
the different samples. 
 
Atomic force microscopy  
The spray-dried powders were applied onto a fresh mica surface using a Gilson pipette tip, 
and slightly blown with pressured nitrogen gas. Freshly cleaved mica (Agar Scientiﬁc, 
Stansted, U.K.) was used as sample substrate. Samples were imaged with a Bruker Dimension 
FastScan Bio AFM in PeakForce Quantitative Nano-Mechanics (QNM) mode (Bruker UK 
Ltd, Coventry, UK). Tap150A (also called as MPP-12120, Bruker) tips (5 N/m, 150 kHz, 
rotated tip, aluminum reflective coating) were used for Peak Force imaging.  
PeakForce QNM is a novel development in AFM techniques. Whilst the tip is driven 
oscillated at its resonant frequency in the traditional Tapping mode, the tip taps the sample 
surface at a frequency substantially lower than its resonant frequency in PeakForce mode, for 
example, 2 kHz vs 150 kHz in the present case. The vertical position of the AFM tip is 
maintained under continuous active control allowing an accurate constant  maximum contact 
force whilst maintain nanoscale spatial resolution (17). The active cantilever control allows a 
simultaneous extraction of quantitative information related to surface properties such as 
stiffness and adhesion alongside the traditional topographic data (18). To calculate sample 
stiffness from the tip-sample interaction force data the Hertzian based DMT (Derjaguin-
Muller-Toporov) model was applied which assumes the contact is between a rigid sphere (the 
silicon AFM tip apex) and a soft flat surface (the polymeric microparticle). Gwyddion 
software (version 2.22) was used for data analysis. 
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RESULTS 
Morphological characterization of microspheres 
The particle size and surface morphology of the microspheres of the different formulations 
were compared via SEM. Although a statistically significant number of particles were not 
analyzed, SEM could be used as an indicator for both particle size and morphology. Figure 2 
shows that there are no striking differences regarding particle size and morphology when 
comparing the three model formulations. Particles are spherical, with a smooth, intact surface 
and an estimated diameter approximately between 1 µm and 7 µm. 
 
 
FIGURE 2 Scanning electron micrographs of the model formulations with following API/ 
PLGA/PVP (w/w/w) ratios: (a). 10/75/15, (b). 20/50/30 and (c). 30/25/45. 
 
Phase behaviour 
MDSC was used to determine the Tgs of the pure compounds, which were 38°C for PLGA, 
56°C for the API and 174°C for PVP under the given experimental conditions. The phase 
behaviour of the model formulations was examined and the resulting thermograms are 
displayed in Figure 3. For each sample two mixing Tgs were observed, the first one 
approximating to the Tg of PLGA and the second one shifting towards the Tg of pure PVP 
(Fig. 3). The known Tg of the API (around 56°C) was not observed in the thermograms. 
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FIGURE 3 MDSC of the model formulations. From top to bottom reversing heat flow with 
following API/PLGA/PVP (w/w/w) ratios: (a). 10/75/15, (b). 20/50/30 and (c). 30/25/45. 
 
Surface chemical analysis 
ToF-SIMS was used to chemically analyze the surfaces of the microspheres and hence solid 
dispersions. The spatial distribution of the API and PLGA at the sample surface is represented 
in Figure 4. There is a negligible amount of PVP observed at the particle surface which is 
consistent with previous studies (8,9) and depicted in Figure 2 of the Supplementary 
Information. At the micron-scale resolution of the ToF-SIMS data the drug seems to be 
homogeneously distributed at the surface of the three model formulations. For the formulation 
containing 20 wt% API a significantly higher intensity for the marker of the API is observed.  
 
Figure 5 illustrates the measured API intensity at the sample surface and hence depicts a 
measure of API surface coverage for the three model formulations. Ranking of the 
formulations based upon the observed API surface coverage is as follows: 30/25/45 < 
10/75/15 < 20/50/30 API/PLGA/PVP wt%, whereas ranking based upon total API content is: 
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30/25/45 < 20/50/30 < 10/75/15 API/PLGA/PVP wt%. Hence the appearance of API at the 
particle surface is not in agreement with the total amount of API present in the microparticles, 
e.g. formulation 30/25/45 API/PLGA/PVP wt% has the highest bulk concentration of API (30 
wt%) but shows the lowest surface coverage compared to the other model formulations.  
 
FIGURE 4 ToF-SIMS secondary ion intensity images of the model formulations with the 
following API/PLGA/PVP (w/w/w) ratios: (a). 10/75/15, (b). 20/50/30, (c). 30/25/45. Panels a 
show results of the total intensity signal. Panels b and c show negative polarity images of 
respectively API (m/z=183) and PLGA (m/z= 142). Panels d show the negative polarity 
overlay images (PVP in red, PLGA in green) (4 mm×4 mm scan size). 
 
Surface topographical analysis 
Simultaneous mapping of topography and surface properties using QNM in PeakForce mode 
revealed the surface structure of the three formulations. Figures 6-8 show topography (3D and 
2D views) along with the corresponding stiffness map for the microspheres of the 10/75/15, 
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20/50/30 and 30/25/45 API/PLGA/PVP wt% samples. The 3D data emphasize that these 
images are acquired from the apex of immobilized microspheres. The 2D representation 
following the background subtraction of the image curvature reveals surface structure in 
details. For the 10 wt% and 30 wt% API samples little surface topographic variation is 
observed with a smooth homogeneous surface evident (Fig. 6A-B, Fig. 8A-B). The 20 wt% 
API sample shows significant heterogeneity in surface topography (Fig. 7A-B). Similarly the 
corresponding stiffness maps only show significant heterogeneity in the 20 wt% API sample 
(Fig. 6C, 7C, 8C). 
 
FIGURE 5 I. Negative ToF-SIMS spectra at m/z 183 (marker API) of the model formulations 
with the following API/PLGA/PVP (w/w/w) ratios: (a). 10/75/15, (b). 20/50/30, (c). 30/25/45. 
II. Histogram representing the intensity at m/z 183 for the three model formulations (1 mm×1 
mm scan size, n=4). 
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FIGURE 6 Peak Force QNM AFM analysis of a spray-dried 10/75/15 API/PLGA/PVP 
particle. (a). 3D representation of the AFM topographic data showing a region of the particle 
displaying a smooth featureless surface, (b). 2D representation of the topographic data 
(following flattening of the data (vertical grey scale 4 nm)) and (c). a corresponding 
sample stiffness map (based upon DMT analysis, lighter being stiffer (arbitrary scale)). 
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FIGURE 7 Peak Force QNM AFM analysis of a spray-dried 20/50/30 
API/PLGA/PVP particle. (a). 3D representation of the AFM topographic data showing a 
region of the particle displaying clear heterogeneity including surface depressions, (b). 2D 
representation of the topographic data (following flattening of the data (vertical grey scale 30 
nm)) and (c). a corresponding sample stiffness map (based upon DMT analysis, lighter being 
stiffer (arbitrary scale)). 
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FIGURE 8 Peak Force QNM AFM analysis of a spray-dried 30/25/45 API/PLGA/PVP 
particle. (a). 3D representation of the AFM topographic data showing a region of the particle 
displaying a relatively smooth surface with some circular features, (b). 2D representation of 
the topographic data (following flattening of the data (vertical grey scale 300 nm)) and (c). a 
corresponding sample stiffness map (based upon DMT analysis, lighter being stiffer (arbitrary 
scale)). Note the small triangular indents at the top of the image are due to a high force 
threshold during the AFM tip’s raw engagement. 
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FIGURE 9 Elucidated structures of the model formulations with following API/PLGA/PVP 
(w/w/w) ratios: (a). 10/75/15, (b). 20/50/30 and (c). 30/25/45. 
 
DISCUSSION 
MDSC was used to thermally study the phase behaviour of the three model formulations. For 
each sample two mixing Tgs were observed, the first one approximating to the Tg of PLGA 
and the second one shifting towards the Tg of pure PVP (Fig. 3). In addition, the absence of a 
Tg around 56°C (Tg of the API) indicates that the API is molecularly dispersed in a phase 
separated system made up of a PLGA-rich phase and a PVP-rich phase. Preceding work has 
already revealed that hollow spheres are formed when PLGA and PVP are spray-dried 
together with a PLGA surface layer and an underlying PVP layer (8,9).
 
The presence of 
PLGA at the particle surface is due to its surface activity and a consequence of restructuring 
of the methyl side groups of PLGA towards the droplet-air surface (8,19). Moreover these two 
polymeric phases display a small degree of miscibility which is determined by the PLGA to 
PVP ratio (8). The additional presence of an API will influence this phase behaviour.  
Phase behaviour of the polymeric PLGA/PVP matrix was studied by estimating the polymer 
miscibility in these binary systems based upon the observed Tgs using the Gordon-Taylor 
equation for binary mixtures (equation 1) (7). 
 
Tgmix = (w1Tg1 + Kw2Tg2) / (w1 + Kw2)       (1) 
19 
 
     
In this equation, the weight fraction of each compound is represented by w, the glass 
transition temperature by Tg and the subscripts 1 and 2 represent the compounds with the 
lowest and the highest glass transition temperatures respectively. The constant K can be 
assessed by using the Simha-Boyer rule (equation 2), with ρ being the density of the 
amorphous compounds. 
 
K ≈ (ρ1Tg1) / (ρ2Tg2)          (2) 
 
Consequently the amount of PVP present in the PLGA layer and the amount of PLGA present 
in the PVP layer could be calculated. The PVP content in the PLGA phase was thus estimated 
to be 15% and the PLGA content in the PVP phase 3% (9). 
 
The complex phase behaviour of ternary, or even quaternary (when taking residual solvent 
into account), systems is however difficult, if not impossible to assess using this equation. An 
extended form of the Gordon-Taylor equation for ternary mixtures has been developed 
(equation 3). 
 
Tgmix = (w1Tg1 + K1w2Tg2 + K2w3Tg3) / (w1 + K1w2 + K2w3)     (3) 
 
With w representing the weight fraction of each compound, Tg the glass transition where the 
subscripts 1, 2 and 3 represent the compounds with the lowest, middle and the highest glass 
transition temperatures, respectively. The constants K1 and K2 are analogously obtained by 
equation 2. 
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This extended formula was originally used to account for residual (plasticizing) solvent (20–
22) and was expanded to the analysis of ternary solid dispersions (23). However, this 
extended form finds limited application due to the contradiction between the complexity of 
ternary mixtures and the assumptions made for this model equation. Generally the Gordon-
Taylor equation assumes additivity of the specific volumes of the compounds involved as well 
as a linear change in volume with temperature (6). Obviously the likelihood that those 
assumptions apply decreases with increasing complexity of the system. 
 
Illustratively equation 3 was applied to the observed Tg of the PLGA-rich phase of the 
20/50/30 API/PLGA/PVP wt% sample (Tg = 42.45°C). Assuming ideal mixing of this ternary 
system, the calculated amount of API could vary between 0 and 10 wt% API in the PLGA-
rich phase. This variation in composition might be translated to differences in the release 
profile and physical stability of the formulation. The above indicates that (M)DSC alone does 
not allow the determination of the ternary composition of the two phases present and is not 
sufficient to characterize these complex ternary system samples as it is unable to inform on 
the distribution of the API in the PLGA-rich surface layer and the underlying PVP-rich phase. 
Owing to this limitation, for these systems MDSC must be applied in combination with 
surface analysis in order to determine the composition. 
 
ToF-SIMS was utilised to chemically elucidate the surface composition of the microspheres 
of the different formulations. Chemical surface analysis by ToF-SIMS revealed that the 
degree of API surface coverage of the solid dispersion clearly differed when formulation 
parameters were changed (Fig. 4-5). Additionally, an inconsistency  was observed between 
the API bulk concentration and surface coverage. The sample with the highest total amount of 
API (30/25/45 API/PLGA/PVP wt%) did not show the highest amount of API present at the 
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surface, in fact it displayed the lowest surface coverage. This discrepancy indicates that the 
API distribution of the drug is influenced by formulation parameters. The observed 
susceptibility of these systems regarding API distribution induced by changes in formulation 
(and likely process) parameters indicates the need for in depth sample characterization, 
combining miscibility, characterization of API surface coverage and spatial API distribution 
at higher resolution. 
 
AFM imaging of the three samples showed identifiable differences between the appearance 
and organization of the formulations. In general, spray-dried particles of the 10/75/15 
API/PLGA/PVP wt% formulation showed a smooth featureless topography with no evidence 
of sample heterogeneity. Corresponding surface stiffness maps also indicated a homogenous 
material with no significant nanoscale variation in mechanical properties (Fig. 6). Similar 
observations were also made for the 30/25/45 API/PLGA/PVP wt% samples. Although 
particles did show some circular topographic features no significant variation in mechanical 
properties was observed (Fig 8), again indicating a compositionally homogeneous surface. In 
contrast, the 20/50/30 API/PLGA/PVP wt% formulation showed some significant 
heterogeneity in its surface topography and composition. There is clear evidence of pits in the 
surface of the order of hundreds of nanometers in diameter and 2-15 nm in depth. The 
stiffness map shows areas of reduced stiffness (darker contrast) in relation to the majority of 
the surface, sometimes but not always associated with the pits (Fig. 7). Whilst AFM does not 
uniquely (chemically) identify components as in ToF-SIMS the observation of complexity at 
the surface of the 20/50/30 as compared to the 10/75/15 and 30/25/45 API/PLGA/PVP wt% 
samples is consistent with the 20 wt% API samples showing a higher than expected ratio of 
API at the surface of the particles. The AFM indicates that the structural pits may be revealing 
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underlying material that contains API and/or that surface heterogeneity (incomplete mixing of 
components) in these samples is related to the higher API surface coverage. 
 
The information regarding the phase behaviour of the polymers obtained by MDSC was 
combined with the information ToF-SIMS provided on the spatial distribution of the API at 
the surface of the microspheres as well as on the ranking of the formulations based on API 
surface coverage. AFM provided spatial information on the distribution of different 
compounds at the microsphere surface at nanoscale resolution. Taken together these 
techniques provide insights into differences in drug distribution (via the observed surface 
coverage) for three differently composed ternary solid dispersions. A schematic illustration of 
the elucidated structures of the three model formulations is shown in Figure 9. 
 
The observed differences between the formulations studied can be explained by the fact that a 
change in formulation parameters (here a change in the ratio API/PLGA/PVP and thus 
composition of the feed solution) can influence particle formation during spray drying. A 
differently composed feed solution can result in different feed viscosity, evaporation rate or 
solidification point of the compounds. These parameters might affect the distribution of the 
API in the formed microspheres and therefore the degree of API surface coverage. This is 
illustrated by the Peclet number (Pe) which is used to predict compound distribution of the 
API during the particle formation process (equation 4).  
 
Pei = κ / 8Di           (4) 
 
In this equation the evaporation rate is represented by ĸ and Di stands for the diffusion 
coefficient of solute i. This formula clearly indicates how a change in evaporation rate might 
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influence API distribution. Evaporation rate can be influenced by a varying feed composition 
as the affinity between solvent-polymer and solvent-drug molecules influences the 
evaporation rate. The extent of this influence will depend on the amount of polymer or drug 
molecules (with affinity for the solvent) present in solution (24). The potential influence of 
feed viscosity on API distribution and (surface coverage) is illustrated by the Stokes-Einstein 
equation which pinpoints the different parameters that influence the diffusion coefficient of a 
compound (equation 5). 
 
D = kBT / 6πηr          (5) 
 
In this equation D is the diffusion coefficient, r the globular radius, T the absolute temperature 
and η the viscosity of the solution. kB is the Boltzmann constant.  
The higher the concentration of a compound in the feed solution, the closer it will be to its 
solubility limit and the faster it will reach the solidification point during the particle formation 
process. This possible difference of solute deposition time might also influence the spatial 
distribution of the API (25). 
 
The lack of substantial differences in microspheres size and morphology (Fig. 2) when 
comparing the three model formulations indicates that differences in formulation parameters 
did not influence particle size and morphology. 
 
In addition to influencing the particle formation process, changing the ratio of the three 
components might result in different mixed phases each displaying different solubility of the 
API and again a different distribution of the API in the spray-dried microspheres. 
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CONCLUSIONS 
This study demonstrated how a combination of (M)DSC and the surface analysing techniques 
ToF-SIMS and AFM offer  synergistic benefits for the characterisation of the phase behaviour 
and drug distribution of ternary solid dispersions (API/PLGA/PVP).  
 
MDSC showed that the investigated formulations consisted of two mixed phases, a PLGA-
rich phase and a PVP-rich phase, in which the API is present as a glass solution. ToF-SIMS 
informed on the spatial composition of the ternary solid dispersions: the PLGA-rich phase 
covers the surface of the microspheres, the PVP-rich phase is situated underneath. The degree 
of API surface coverage varies for the different formulations but is not in agreement with the 
bulk API concentration. AFM imaging and mechanical mapping coupled nanoscale spatial 
information about the microsphere surface to these findings, indicating structural and 
compositional heterogeneity in the 20 wt% API samples (compared to 10 wt% and 30 wt% 
API samples), which was consistent with their higher than expected surface coverage of API. 
 
Interestingly, the distribution of the API in the ternary solid dispersions depended on 
formulation parameters. The extent of API surface coverage and therefore the distribution of 
the API over both polymeric phases differed significantly for the three formulations. As the 
location of the API in the microspheres might significantly influence the performance of the 
formulation (release behaviour and physical stability) insight into how formulation and 
process parameters influence the spatial distribution of the drug in these ternary solid 
dispersions would allow rational design of control release profiles and stability performance. 
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